Managing Docs in Europe
Companies who have tried to promote pharmacy benefit management in Europe have found the going rough, even while acknowledging that Europe will need different models of PBM than the US. Now one of the US PBMs, Caremark, is tentatively exploring whether US managed care's latest iteration, physician practice management (PPM), can work in Europe.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.